ALKERMES | ALKS - 营业利润

股票价格

33.31

每天变化

-0.60 -1.77%

每月一次

13.42%

每年

19.65%

Q2 预测

32.32

金融业

USD

USD 2.49B

现金及等价物

USD 388.57M

USD 46.21M

USD 1.93B

USD 543.44M

USD 71.6M

股息收益率

0

USD -10.95M

USD 100.31M

1.8K

EPS每股收益

USD 0.29

股本和储备

USD 1.82B

USD 338.34M

债务利息支出

USD 12.28M

USD 11.94M

USD 285.82M

USD 5.49B

USD 49.34M

USD 326.44M

USD -10.95M

普通股股本

USD 165.61M

19.54

USD 100.74M

USD 384.5M

销售和管理费用

USD 187.2M

USD 196.63M

贸易债权人

USD 107.95M

应收帐款人

USD 334.03M

	营业利润	更改		日
AbbVie	USD 5.81B		1.23B	2025-12
Acadia Pharmaceuticals	USD 17.39M		18.36M	2025-12
ALKERMES	USD -10.95M		100.03M	2025-12
Amgen	USD 3.96B		464M	2025-12
Biogen	USD 659.6M		192.2M	2025-09
BioMarin Pharmaceutical	USD 198.39M		230.08M	2025-12
Bristol-Myers Squibb	USD 4.2B		562M	2025-12
Coherus Biosciences	USD -39.08M		3.65M	2025-12
Eli Lilly	USD 8.99B		599.9M	2025-12
Gilead Sciences	USD 2.96B		551M	2025-12
Heron Therapeutics	USD 38K		3.83M	2025-12
Ionis Pharmaceuticals	USD -215M		54.82M	2025-12
J&J	USD 6.62B		1.03B	2026-03
Malin Corporation	EUR -1.1M		400K	2024-12
Merck	USD 6.24B		318M	2025-12
Minerva Neurosciences	USD -21.85M		17.48M	2024-12
Nektar Therapeutics	USD -19.09M		15.26M	2025-12
Neurocrine Biosciences	USD 227.9M		11.4M	2025-12
Otsuka Holdings	JPY 67.25B		101.57B	2025-12
Ovoca Bio	EUR -1.16M		4.48M	2025-06
Pfizer	USD 4.65B		3.99B	2025-12
Regeneron Pharmaceuticals	USD 898.6M		211.3M	2025-12
Vertex Pharmaceuticals	USD 1.26B		24.5M	2025-12